Oklahoma City biotech startup seeks funding for clinical trials

Oklahoma City’s EpimedX trying to develop treatment for sickle cell disease, which affects more than 90,000 people in the United States.

BY BRIANNA BAILEY Published: January 10, 2013
Advertisement
;

Local biotech startup EpimedX believes a drug known as Edx-17 could help treat annually more than 90,000 patients with sickle cell disease in the United States.

“Sickle cell...

Oklahoman subscribers have access to this article. Unlock it below.

What is this? Learn more.

NewsOK.com has disabled the comments for this article.
Advertisement


Trending Now



AROUND THE WEB

  1. 1
    KFOR: Biological mother wants adopted son back from powerful family
  2. 2
    Authorities: Dozen arrested in Oklahoma ranch meth lab investigation
  3. 3
    Photo Of Obama In Attack Ad Is Photoshopped From Hospital Trip After Aurora Shooting
  4. 4
    WATCH: Trailer for 'Iverson' documentary
  5. 5
    Herschel Walker says he could still play in NFL
+ show more